Open Access

Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

E. Karamitrousis

E. Karamitrousis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Karamitrousis, E.
, 
I. Balgkouranidou

I. Balgkouranidou

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Balgkouranidou, I.
, 
N. Xenidis

N. Xenidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Xenidis, N.
, 
K. Amarantidis

K. Amarantidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Amarantidis, K.
, 
E. Biziota

E. Biziota

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Biziota, E.
, 
T. Koukaki

T. Koukaki

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Koukaki, T.
 and 
S. Kakolyris

S. Kakolyris

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Search for this author on
Sciendo|Google Scholar
Kakolyris, S.
  
May 07, 2022
Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: May 07, 2022
Page range: 72 - 76
Received: Oct 14, 2021
Accepted: Dec 23, 2021
DOI: https://doi.org/10.2478/fco-2021-0010
Keywords
© 2021 Karamitrousis E. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Gastric cancer is one of the most common cancers worldwide. The amount of cell-free DNA (cfDNA) in the blood of patients with gastric cancer was found to be higher than that of healthy controls (69.1 ng/μL vs. 34.8 ng/μL). Patients with cfDNA ≤ 50 ng/μL were found to have an increased overall survival (OS) and progression free survival (PFS) than in patients with cfDNA > 50 ng/μL.

Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology
Journal RSS Feed